Guardant Health | Conquering Cancer With Data
Guardant Health is a leading precision medicine company focused on transforming patient care and conquering cancer with data.
Careers - Guardant Health
Our values are driven by a strong passion to improve human health for all patients with cancer. These values guide what we do each and every day, from how we solve the most complex problems to how we collaborate across diverse functions.
Guardant Health, Inc. - Guardant Health Shield Platform Selected …
Jan 7, 2025 · Guardant Health Shield multi-cancer detection test selected on basis of strong performance in predicting presence of cancers and cancer tissue of origin; Pilot study by National Cancer Institute’s Cancer Screening Research Network will inform design of future research evaluating use of multi-cancer detection blood tests to screen for cancer
Guardant Health, Inc. - Guardant Health to Share Data Supporting ...
Oct 28, 2024 · PALO ALTO, Calif.--(BUSINESS WIRE)-- Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced the company and its research collaborators will present data supporting the critical role of blood-based testing in increasing overall colorectal cancer (CRC) screening adherence at the American College of ...
Guardant Health
New to Guardant? Register new account. © 2025 Guardant Health, Inc. All rights reserved.
Guardant Health to Participate in Upcoming Investor Conferences
Nov 1, 2024 · Guardant Health is a leading precision oncology company focused on guarding wellness and giving every person more time free from cancer. Founded in 2012, Guardant is transforming patient care by providing critical insights into what drives disease through its advanced blood and tissue tests, real-world data and AI analytics.
Shield™ for Cancer Screening - Guardant Health
Cancer screening is a proven way to detect cancer early, when it’s most treatable. However, 1 in 3 eligible Americans do not complete colorectal cancer screening in part because they find the current options unpleasant or inconvenient. 1 Blood-based screening tests like Shield that can be completed as part of a simple blood draw have the potential to improve screening adherence …
Guardant Health Named to TIME’s List of the Best Inventions of 2024
Oct 30, 2024 · Shield ™, the first FDA-approved, Medicare-reimbursed colorectal cancer screening blood test, named to the Medical Care list Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced the inclusion of its blood-based colorectal cancer screening product Shield in TIME’s annual list of the Best Inventions, which ...
Guardant Health, Inc. - Meaningful Insights Biotech Analytics …
Dec 20, 2024 · Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, and Meaningful Insights Biotech Analytics (MiBA), an innovative healthcare technology company, today announced a unique partnership aimed at optimizing the use of biomarker testing and data analytics to advance precision medicine in patient care throughout the MiBA Network.
Our Approach - Guardant Health
Discover how Guardant Health is dedicated to enhancing patient outcomes and supporting individuals at every stage of their cancer journey.